Global Ocular Drug Delivery Technology Market Is Poised To Grow At A CAGR of 8.2% by 2032

As per a recent report published by Fact.MR, the global ocular drug delivery technology market is poised to grow at a CAGR of 8.2% from 2022 to 2032, expected to close at a valuation of US$ 39 Billion. A rise in the geriatric population followed by upsurge in occurrence of eye disease such as glaucoma, cataract and macular degeneration, has augmented the demand for ophthalmic drugs and treatment options.

From 2015 to 2021, the market for ocular drug delivery technology grew at a CAGR of 7.4%, closing at a value of US$ 16.4 Million. As of 2022, the industry is likely to reach US$ 17.74 Billion. It is anticipated that glaucoma cases will surpass 100 billion by 2040, while macular degeneration shall reach nearly 200 billion by 2022-end. These increasing cases are poised to heighten prospects for the ocular drug delivery market in the forecast period (2022-2032).

Recently, there has been an increment in the geriatric population followed by upsurge in occurrence of eye disease such as glaucoma, cataract and macular degeneration, augmenting the demand of ophthalmic drug in countries like U.S & Canada.

Download Free Sample Copy of This Report:

https://www.factmr.com/connectus/sample?flag=S&rep_id=4802

Key Takeaways from the Market Study

• Global ocular drug delivery technology market to flourish 1.6x from 2022-2032

• Solution-based formulation of ocular drug delivery technology to be a top-selling category, capturing more than 60% market and flourishing at a 17% CAGR until 2032

• By technology, Intraocular implants for the healthcare industry to expand at a CAGR of 7.7%

• U.S to emerge as the fastest-growing Ocular Drug Delivery Technology market, documenting a 7.1% CAGR

• China to be the 2nd most opportunistic market, expected to be valued at US$ 3.5 Billion in 2032

"Swelling adoption of fresh drug delivery technologies such as micro- and nanoparticles and implantable devices for posterior eye therapy is projected to unlock growth opportunities for advanced ocular drug treatments," comments a Fact.MR analyst.

To learn more about Ocular Drug Delivery Technology Market, you can get in touch with our Analyst

https://www.factmr.com/connectus/sample?flag=AE&rep_id=4802

Key Companies Profiled by Fact.MR

• Ocular Therapeutix, Inc.
• Alimera Sciences
• Allergan Plc.
• Valeant Pharmaceuticals International (Bausch Health Company), Inc.
• Santen Pharmaceutical Co., Ltd.
• Bepreve
• Istalol
• Besivance
• Alrex
• Zylet

Key Segments Covered in the Ocular Drug Delivery Technology Industry Survey

• Ocular Drug Delivery Technology by Type :

o Topical Ocular Drug Delivery Technology
o Ocular Drug Delivery Inserts:
 Non-erodible Ocular Drug Delivery Technology
 Erodible Ocular Drug Delivery Technology
o Iontophoresis Ocular Drug Delivery Technology

o Intraocular Implants:

 Biodegradable Ocular Drug Delivery Technology
 Non-biodegradable Ocular Drug Delivery Technology
o In-Situ Gel & Punctal Plugs Ocular Drug Delivery Technology
o Others

• Ocular Drug Delivery Technology by Formulation :

o Solution based Ocular Drug Delivery Technology
o Suspension based Ocular Drug Delivery Technology
o Emulsion based Ocular Drug Delivery Technology
o Liposomes & Nanoparticles based Ocular Drug Delivery Technology
o Ointment based Ocular Drug Delivery Technology

• Ocular Drug Delivery Technology by Disease Type :

o Ocular Drug Delivery Technology for Glaucoma
o Ocular Drug Delivery Technology for Diabetic Retinopathy
o Ocular Drug Delivery Technology for Dry Eye Syndrome
o Ocular Drug Delivery Technology for Macular Degeneration
o Ocular Drug Delivery Technology for Diabetic Macular Edema
o Ocular Drug Delivery Technology for Cataract
o Others

• Ocular Drug Delivery Technology by Region :

o North America Ocular Drug Delivery Technology Market
o Latin America Ocular Drug Delivery Technology Market
o Europe Ocular Drug Delivery Technology Market
o Asia Pacific Ocular Drug Delivery Technology Market
o Middle East & Africa Ocular Drug Delivery Technology Market

Questionnaire answered in the Ocular Drug Delivery Technology Market report include:

• How the market for Ocular Drug Delivery Technology has grown?
• What is the present and future outlook of the global Ocular Drug Delivery Technology on the basis of region?
• What are the challenges and opportunities for the Ocular Drug Delivery Technology?
• Why the consumption of Ocular Drug Delivery Technology highest in region?
• In which year segment is expected to overtake segment?

Get Free Access to this Report :

https://www.factmr.com/checkout/4802

What makes Fact.MR report stand out from others?

• MR follows a six-point mechanism known as E.V.O.L.V.E. (Evaluate. Visualize. Overcome. Leverage. Verify. Eradicate.). The report is specially created to assess the COVID-19 impact on the Ocular Drug Delivery Technology market. This mechanism focuses on almost all the factors in a definite manner to provide the best research report for the market stakeholders.

• Evaluate: A Fact.MR report evaluates every small aspect that can prove to be a growth generator for the Ocular Drug Delivery Technology market, thus, making it different and special from other reports.

• Visualize: The authors involved in the research activities visualized the post-COVID-19 era so that the key stakeholders of market get an overview and helps them take certain steps to ensure continuous growth during the forecast period.

• Overcome: The report scrutinizes on points that can prove to be an Achilles heel to the Ocular Drug Delivery Technology market and assists to create strategies to overcome the obstacles that may hinder the growth of the Ocular Drug Delivery Technology market.

• Leverage: The Ocular Drug Delivery Technology market can leverage certain aspects that can prove beneficial for the increase in growth rate. Fact.MR covers all the points on which the key stakeholders can leverage upon.

• Verify: Research is done systematically to assure validation of all the aspects covered in the report. All the points are rechecked and verified thoroughly to avoid flaws and fake information.

• Eradicate: Last but not the least, this aspect helps the key stakeholder eradicate all the obstacles that come between the growth rate and the Ocular Drug Delivery Technology market.

Explore Fact.MR's More Insights on the Healthcare Domain

Skincare Device Market: https://www.prnewswire.com/news-releases/sales-of-skincare-devices-to-surpass-uss-43-48-bn-as-prevalence-of-dermatological-diseases-increases-factmr-report-301506974.html

ENT Medical Devices Market: https://www.prnewswire.com/news-releases/ear-nose-throat-ent-medical-devices-manufacturers-target-applications-in-cataract--glaucoma-treatment-factmr-301262063.html

21st floor , 136 Sejong-daero,
Seoul,100-768
South Korea
Phone: +1 (628) 251-1583
Email: sales@factmr.com

Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed . Our sales offices in United States and Dublin, Ireland. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.